5-methylcytosine has been researched along with Precancerous Conditions in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Chu, C; Gao, X; Jin, Y; Tang, F; Wang, H; Zhang, K; Zhang, W; Zhang, Z; Zhou, J; Zou, L; Zou, Q | 1 |
Cheng, Q; Feng, X; Li, M; Li, X; Liu, G; Luo, S; Sun, F; Sun, W; Tang, J; Tao, J; Tao, X; Wu, C; Wu, S; Wu, W; Xiao, Z; Yu, Y; Yun, Z; Zheng, L | 1 |
Chen, XL; Cuevas-Nunez, MC; Gomes, CBF; Lian, CG; Murphy, GF; Ramsey, MR; Woo, SB; Xu, S; Xu, T; Zhan, Q | 1 |
Balch, C; Chao, TK; Chen, CW; Chen, LY; Hsu, YW; Huang, RL; Lai, HC; Liao, CC; Mao, SP; Su, PH; Wu, TI | 1 |
Cai, M; Cui, Y; Gao, P; Lin, J; Lin, S; Liu, J; Lu, X; Song, Y; Sui, Y; Zhong, Y; Zhou, P; Zhu, Y | 1 |
Dresser, KA; Larson, AR; Lezcano, C; Lian, CG; Mihm, MC; Murphy, GF; Scolyer, RA; Shi, YG; Thompson, JF; Woda, BA; Yosufi, B; Zhan, Q | 1 |
Blanquart, C; Deshayes, S; Fonteneau, JF; Grégoire, M; Guilly, MN; Hulin, P; Le Martelot, V; Liddell, C; Nader, JS; Ouacher, A; Pouliquen, DL; Robard, M; Roulois, D | 1 |
Compare, D; Coppola-Bottazzi, E; D'Armiento, FP; Liguori, E; Masone, S; Nardone, G; Persico, G; Rocco, A; Romano, M; Suriani, R | 1 |
Bell, WC; Grizzle, WE; Heimburger, DC; Henao, OL; Jones, J; Niveleau, A; Piyathilake, CJ | 1 |
Bell, WC; Frost, AR; Grizzle, WE; Heimburger, DC; Johanning, GL; Niveleau, A; Oelschlager, D; Piyathilake, CJ; Weiss, H | 1 |
Breznik, T; Butel, JS; Cohen, JC; Gama-Sosa, MA; Medina, D | 1 |
11 other study(ies) available for 5-methylcytosine and Precancerous Conditions
Article | Year |
---|---|
Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion.
Topics: 5-Methylcytosine; Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Dioxygenases; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Precancerous Conditions; Proto-Oncogene Proteins; Receptor, ErbB-2 | 2020 |
5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
Topics: 5-Methylcytosine; Adenoma; Adult; Aged; Cell-Free Nucleic Acids; Cluster Analysis; Colorectal Neoplasms; DNA, Neoplasm; Female; Genome, Human; Humans; Male; Middle Aged; Molecular Sequence Annotation; Neoplasm Staging; Precancerous Conditions | 2021 |
Biological significance of 5-hydroxymethylcytosine in oral epithelial dysplasia and oral squamous cell carcinoma.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cells, Cultured; Disease Models, Animal; DNA Methylation; Early Diagnosis; Fibroma; Humans; Immunoblotting; Immunoenzyme Techniques; Keratinocytes; Lichen Planus, Oral; Mice; Mouth Neoplasms; Precancerous Conditions; Prognosis | 2018 |
TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions.
Topics: 5-Methylcytosine; Animals; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; HeLa Cells; Heterografts; Humans; Mice; Mixed Function Oxygenases; Neoplastic Stem Cells; Precancerous Conditions; Proto-Oncogene Proteins; Squamous Intraepithelial Lesions of the Cervix; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vimentin; Zinc Finger E-box-Binding Homeobox 1 | 2019 |
5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
Topics: 5-Methylcytosine; Cell-Free Nucleic Acids; Colorectal Neoplasms; DNA Methylation; DNA, Neoplasm; Epigenomics; Gene Expression Regulation, Neoplastic; Gene Ontology; Genomics; Humans; Precancerous Conditions; Sequence Analysis, DNA | 2019 |
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; Female; Humans; Male; Melanoma; Middle Aged; Nevus; Precancerous Conditions; Skin Neoplasms; Young Adult | 2014 |
Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine.
Topics: 5-Methylcytosine; Animals; Asbestos, Crocidolite; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p18; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Epithelial Cells; Epithelium; Humans; Karyotype; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mixed Function Oxygenases; Precancerous Conditions; Proto-Oncogene Proteins; Rats; Rats, Inbred F344 | 2016 |
Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis.
Topics: 5-Methylcytosine; Adult; Biomarkers, Tumor; Case-Control Studies; DNA Methylation; Dyspepsia; Early Detection of Cancer; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Precancerous Conditions; Prognosis; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2011 |
Pattern of nonspecific (or global) DNA methylation in oral carcinogenesis.
Topics: 5-Methylcytosine; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Case-Control Studies; DNA Methylation; Epithelium; Humans; Immunohistochemistry; Mouth Mucosa; Mouth Neoplasms; Precancerous Conditions; Smoking | 2005 |
Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression.
Topics: 5-Methylcytosine; Antibodies, Monoclonal; Bronchi; Carcinoma, Squamous Cell; Cytosine; Disease Progression; Disease Susceptibility; DNA Methylation; DNA, Neoplasm; Fluorescent Antibody Technique, Indirect; Genetic Predisposition to Disease; Humans; Hyperplasia; Lung Neoplasms; Precancerous Conditions; Respiratory Mucosa; Smoking | 2001 |
Mammary preneoplasia and tumorigenesis in the BALB/c mouse: structure and modification of mouse mammary tumor virus DNA sequences.
Topics: 5-Methylcytosine; 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Transformation, Neoplastic; Cytosine; DNA Restriction Enzymes; DNA, Viral; Female; Genes, Viral; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Methylation; Mice; Mice, Inbred BALB C; Precancerous Conditions; Recombination, Genetic; Virus Replication | 1987 |